• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Teledyne to Acquire Scientific Imaging Businesses of Roper Technologies

Share:

December 24, 2018

Teledyne Technologies Incorporated and Roper Technologies, Inc. jointly announced today that they have entered into a definitive agreement under which Teledyne will acquire the Scientific Imaging businesses of Roper for $225 million in cash. The Scientific Imaging businesses include Princeton Instruments, Photometrics and Lumenera, as well as other brands.

The Scientific Imaging businesses provide a range of imaging solutions, primarily for life sciences, academic research and customized OEM industrial imaging solutions. Princeton Instruments and Photometrics manufacture state-of-the-art cameras, spectrographs and optics for advanced research in physical sciences, life sciences research and spectroscopy imaging. Applications and markets include materials analysis, quantum technology and cell biology imaging using fluorescence and chemiluminescence. Lumenera primarily provides rugged USB-based customized cameras for markets such as traffic management, as well as life sciences applications.

“These Scientific Imaging businesses have similar capabilities and are highly complementary to Teledyne’s products and markets,” said Robert Mehrabian, Chairman and Chief Executive Officer of Teledyne. “Teledyne is a company committed to science and discovery. We are a key partner to high-technology businesses, government agencies and academic institutions across the globe. Princeton Instruments and Photometrics will provide Teledyne new products serving life sciences customers and markets, while Teledyne will offer Lumenera greater opportunities in the industrial domain.”

“Teledyne is an ideal home for our Scientific Imaging businesses, their customers and our employees,” said Neil Hunn, Roper’s President and Chief Executive Officer. “We are thankful for the contributions these businesses have made to Roper and we wish them continued success. The proceeds from this transaction will enhance our ability to deploy capital and continue to compound value for our shareholders.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The transaction is anticipated to close in the first quarter of 2019, and is subject to customary closing conditions, including regulatory approval.

Date: December 24, 2018

Source: Teledyne Technologies

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • PureTech and Nektar Call Off Rumored MergerPureTech and Nektar Call Off Rumored Merger
  • VirTrial Acquires Virtual Care Management Platform SnapMDVirTrial Acquires Virtual Care Management Platform SnapMD
  • The Top 100 Venture CapitalistsThe Top 100 Venture Capitalists
  • JP Morgan Preview: Small, Medium and Large, with a Lot of M&A SpeculationJP Morgan Preview: Small, Medium and Large, with a Lot of M&A Speculation
  • 7 Supply Chain Management Areas Where AI and ML Can Realize The Greatest Cost Savings7 Supply Chain Management Areas Where AI and ML Can Realize The Greatest Cost Savings
  • Walgreens Boots Alliance, Microsoft, Adobe Expand Partnership to Launch Personalized Prescription for PatientsWalgreens Boots Alliance, Microsoft, Adobe Expand Partnership to Launch Personalized Prescription for Patients
  • Patient Co-creation is a Tall, But Worthwhile, Order for Health InnovatorsPatient Co-creation is a Tall, But Worthwhile, Order for Health Innovators
  • Sherlock Biosciences raises $31M to apply CRISPR technology to diagnosticsSherlock Biosciences raises $31M to apply CRISPR technology to diagnostics

Trending This Week

  • New tools and acquisitions from OptumRx, ScionHealth.
  • In the wake of Dobbs, women’s health is ‘Ripe for investment’
  • Market Skeptical Following Sen. Warren’s Antitrust Allegations
  • Rogers, Shaw tick lower amid a report that Industry Minister in no hurry to Ok deal
  • ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, furthering its Ambition to Become the Global Leader in Regenerative Therapies
  • LGM Pharma Acquires Pharmaceutical Development and Manufacturing Unit of Nexgen Pharma

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications